Αναζήτηση
Αποτελέσματα 1-10 από 16
Differential expression of hypoxia-inducible factor 1 alpha in non-small cell lung cancer and small cell lung cancer
(2012)
OBJECTIVES: The aim of this study was to compare the expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in small cell lung cancer and subtypes of non-small cell lung cancer and examine ...
Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects
(2010)
Background: This study aimed to examine whether EBV seropositive patients with lung cancer have an altered virus-specific CTL response, as compared to age-matched healthy controls and whether any variation in this response ...
Anti-survivin antibody responses in lung cancer
(2009)
Existing evidence regarding spontaneous anti-survivin humoral responses in lung cancer is inconclusive. Moreover, despite that cancer cell death elicited by radiotherapy and some chemotherapeutic agents seems to be ...
VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer
(2009)
The aim of the present study was to evaluate the levels of VEGF, 8-isoprostane and TNF-alpha in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible ...
Mesothelioma mortality in Greece from 1983 to 2003
(2009)
To present summary statistics of the Greek mesothelioma epidemic including summaries by occupation and geographical area. The National Statistics Service provides our data, which contain all deaths from 1983 to 2003 where ...
Foxp3 expression in human cancer cells
(2008)
Objective: Transcription factor forkhead box protein 3 (Foxp3) specifically characterizes the thymically derived naturally occurring regulatory T cells (Tregs). Limited evidence indicates that it is also expressed, albeit ...
Naturally occurring tumor-specific CD8(+) T-cell precursors in individuals with and without cancer
(2010)
Boosting pre-existing, naturally occurring cytolytic CD8(+) T-cell (CTLs) responses directed against class-I MHC-restricted peptides of tumor antigens, represents a primary goal of cancer immunotherapy. The number of ...